Back

Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Influence of metabolic or infection disease on the heart HIV and Cardiovascular Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Thorsten Leucker

Johns Hopkins University, Baltimore (United States of America)

6 More presentations in this session

Presentation thumbnail
Lung ultrasound guided dry-weight probing reduces left and right atrial dimensions and left ventricular filling pressures in hemodialysis patients with hypertension
Doctor E. Pagourelias (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Structural or functional left sided heart disease found on echocardiographic screening is associated with a higher risk of death in patients with end stage renal disease receiving haemodialysis
Doctor A. Axelsson Raja (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Left ventricular myocardial mass index is a predictor of clinical outcomes in patients with Fabry disease
Professor S. Moiseev (Moscow, RU)
Abstract Slides Video
Presentation thumbnail
Decreased CD177 expression and its association with intravenous immunoglobulin resistance in Kawasaki disease
Doctor Y. Huang (Kaohsiung, TW)
Abstract
Presentation thumbnail
Left ventricular systolic function in patients with systemic lupus erythematosus and its association with cardiovascular events
Doctor T. Gegenava (Tbilisi, GE)
Abstract Slides Video

Access the full session

Session thumbnail
Influence of metabolic or infection disease on the heart

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources